Oxycodone/Naloxone Sandoz 20 mg/10 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oxycodone/naloxone sandoz 20 mg/10 mg

sandoz pharmaceuticals d.d., slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Oxycodone/Naloxone Sandoz 10 mg/5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oxycodone/naloxone sandoz 10 mg/5 mg

sandoz pharmaceuticals d.d., slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Oxycodone/Naloxone Sandoz 5 mg/2,5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oxycodone/naloxone sandoz 5 mg/2,5 mg

sandoz pharmaceuticals d.d., slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Oxycodone/Naloxone Sandoz 40 mg/20 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oxycodone/naloxone sandoz 40 mg/20 mg

sandoz pharmaceuticals d.d., slovinsko - oxykodón a naloxón - 65 - analgetica - anodyna

Comirnaty Európska únia - slovenčina - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

INOmax Európska únia - slovenčina - EMA (European Medicines Agency)

inomax

linde healthcare ab - oxid dusnatý - hypertension, pulmonary; respiratory insufficiency - ostatné produkty dýchacej sústavy - inomax, v spojení s ventilačnej podpory a iných vhodných účinných látok, je uvedené:na liečbu novorodencov dojčiat ≥34 týždňov gravidity s hypoxic respiračné zlyhanie spojené s klinickými alebo echocardiographic dôkazy, pľúcnej hypertenzie, s cieľom zlepšiť okysličenie a znížiť potrebu extracorporeal membrány okysličenie;ako súčasť liečby z peri - a pooperačnej pľúcnej hypertenzie u dospelých a novorodencov novorodencov, dojčiat a batoliat, detí a dospievajúcich vo veku 0-17 rokov v spojení na operáciu srdca, v záujme selektívne zníženie pľúcny arteriálny tlak a zlepšiť právo komorovej funkcie a okysličenie.

Breakyl Start Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

breakyl start

mylan ire healthcare limited, Írsko - fentanyl - 65 - analgetica - anodyna

STADATUSSIN perorálny roztok Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stadatussin perorálny roztok

stada arzneimittel ag, nemecko - pentoxyverín - 36 - antitussica

Ibuprofen STADA 40 mg/ml perorálna suspenzia Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ibuprofen stada 40 mg/ml perorálna suspenzia

stada arzneimittel ag, nemecko - ibuprofén - 07 - analgetica, antipyretica

MIGRATRIP 10 mg perorálny gél Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

migratrip 10 mg perorálny gél

aziende chimiche riunite angelini francesco a.c.r.a.f.spa, taliansko - rizatriptán - 33 - antimigraenica,antiserotonica